eXoZymes (EXOZ) vs Hyperion DeFi (HYPD)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
eXoZymes (EXOZ) has outperformed Hyperion DeFi (HYPD) over the past year, losing 59.7% versus a loss of 62.9%. Hyperion DeFi is the larger company by market cap ($51.2 million vs $49.0 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | EXOZ | HYPD |
|---|---|---|
| Share price | $5.27 | $3.37 |
| Market cap | $49.04M | $51.16M |
| 1-day change | -4.87% | -6.27% |
| YTD return | -51.65% | -5.48% |
| 1-year return | -59.68% | -62.86% |
| 5-year return | — | -99.21% |
| EPS (TTM) | $-1.19 | $-6.46 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $18.40 | $9.50 |
| 52-week low | $4.35 | $2.34 |
| Distance from 52-week high | -71.36% | -64.58% |
| Analyst consensus | strong_buy | none |
| Avg. price target upside | — | +192.12% |
| Average volume | 6.97K | 445.34K |
| Shares outstanding | 9.30M | 15.20M |
| Employees | 32 | 9 |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About eXoZymes
EXOZ stock →eXoZymes, Inc. operates as a development stage biotechnology company.
Healthcare · Biotechnology · 32 employees
About Hyperion DeFi
HYPD stock →Hyperion DeFi, Inc., a DeFi company, engages in building on Hyperliquid. It operates through two segments: Ophthalmic Technology and Digital Assets.
Healthcare · Biotechnology · 9 employees
EXOZ vs HYPD FAQ
Which is bigger, eXoZymes or Hyperion DeFi?
Hyperion DeFi (HYPD) is larger, with a market capitalization of $51.16M compared with $49.04M for eXoZymes (EXOZ).
Which stock has performed better over the past year, EXOZ or HYPD?
EXOZ returned -59.68% over the past 12 months, compared with -62.86% for HYPD (price return, excluding dividends). Past performance does not predict future results.
Are eXoZymes and Hyperion DeFi in the same industry?
Yes. Both are classified in the Biotechnology industry within the Healthcare sector.